Bristol-Myers Squibb Company 6.875% 01-AUG-2097Bristol-Myers Squibb Company 6.875% 01-AUG-2097Bristol-Myers Squibb Company 6.875% 01-AUG-2097

Bristol-Myers Squibb Company 6.875% 01-AUG-2097

Compare with Bristol-Myers Squibb Company 6.875% 01-AUG-2097



Key terms


Outstanding amount
‪56.24 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
6.88%
Coupon frequency
Semi-annual
Maturity date
Aug 1, 2097
Term to maturity
71 years

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
Issue date
Aug 12, 1997
ISIN
US110122AC22
CUSIP
110122AC2
FIGI
BBG00004NXF6
Identifiers
ISIN US110122AC22
CFI code
DTFNGR
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.